Načítá se...
Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients
BACKGROUND: Anti-TNF treatment may be useful for the treatment of patients with refractory juvenile dermatomyositis (JDM). The aim of this study was to describe the use of infliximab and adalimumab therapy in juvenile dermatomyositis as an adjunctive treatment. METHODS: Sixty children recruited to t...
Uloženo v:
| Vydáno v: | Arthritis Res Ther |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7161150/ https://ncbi.nlm.nih.gov/pubmed/32293539 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-020-02164-5 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|